Johnson & Johnson
JNJ· Manufacturing· Fiscal year ends in December
J. Duato is the CEO of Johnson & Johnson and was paid $32.8M in FY2025 (Dec), up 35%.
Executives6
See all- 1J. DuatoChairman/CEOFY2025
- 2J. WolkEVP, CFOFY2025
- 3J. TaubertEVP, Worldwide Chair PharmaceuticalsFY2025
- 4Joaquin DuatoChair of the BoardFY2021
- 5J. ReedEVP, Innovative Medicine, R&DFY2025
- 6T. SchmidEVP, WWC, MedTechFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allJohnson & Johnson paid its 5 named executives $82.7M in total in FY2025 (Dec). CEO J. Duato was paid $32.8M of that.
| Name | |||
|---|---|---|---|
| J. DuatoChairman/CEO | |||
| J. WolkEVP, CFO | |||
| J. TaubertEVP, Worldwide Chair Pharmaceuticals | |||
| J. ReedEVP, Innovative Medicine, R&D | |||
| T. SchmidEVP, WWC, MedTech | Not disclosed | ||
| Joaquin DuatoChair of the Board | Not disclosed | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers3
See allThe FY2023 (Dec) proxy of Johnson & Johnson names 3 peer companies for pay. Pay versus performance data of Johnson & Johnson for that year is not on file, so it has no rank.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board15
See all- A. M. MulcahyDirector · 15 yr on the boardIndependentAudit, Nominating & Corporate Governance (Chair)—Paid as an executive
- Jennifer A. DoudnaDirector · 6 yr on the boardIndependentNominating & Corporate Governance, Science & Technology—Paid as an executive
- Hubert JolyDirector · 5 yr on the boardIndependentAudit, Nominating & Corporate Governance—Paid as an executive
- Darius AdamczykDirector · 2 yr on the boardIndependentAudit (Chair), Compensation & Benefits—Paid as an executive
- Eugene A. WoodsDirector · 1 yr on the boardIndependentCompensation & Benefits—Paid as an executive
- Bob WoodruffDirector · -1 yr on the boardIndependent—Paid as an executive
The board of the latest proxy (FY2024).
Shared directors
- ChevronMarillyn A. Hewson1 shared
- Tempus AIJennifer A. Doudna1 shared
Activity
No new filings about this company in the feed.
Filings33
See all| Current report | 8-K | Aug 4, 2026 | — |
| Current report | 8-K | Apr 28, 2026 | — |
| Proxy statement | DEF 14A | Mar 11, 2026 | FY2025 |
| Annual report | 10-K | Feb 11, 2026 | FY2025 |
| Current report | 8-K | Sep 9, 2025 | — |
| Current report | 8-K | Jun 10, 2025 | — |
